Stitch Fix (NASDAQ: SFIX) CTO exercises options, sells 70K shares under plan
Rhea-AI Filing Summary
Stitch Fix, Inc. Chief Prod/Technology Officer Anthony Bacos exercised employee stock options for 50,000 shares of Class A common stock at an exercise price of $2.48 per share, then sold 70,000 shares in open-market transactions on July 27, 2026.
The trades were executed under a Rule 10b5-1 trading plan entered March 17, 2026, at weighted average prices of $3.7741 and $3.7389 per share. Following the option exercise, he held 372,543 employee stock options directly.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
4 txns
Insider
Bacos Anthony
Role
Chief Prod/Technology Officer
Sold
70,000 shs ($263K)
Approx. gross sale proceeds
$263K
Approx. exercise cost
$124K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) F1, F4 | 50,000 | $0.00 | $0.00 |
| Exercise | Class A Common Stock F1 | 50,000 | $2.48 | $124K |
| Sale | Class A Common Stock F1, F2 | 50,000 | $3.7741 | $189K |
| Sale | Class A Common Stock F1, F3 | 20,000 | $3.7389 | $75K |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 372,543 shares (Direct);
Class A Common Stock — 971,994 shares (Direct)
Footnotes (4)
- F1. This transaction was made pursuant to a Rule 10b5-1 plan entered into on March 17, 2026.
- F2. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.65 to $3.825 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.645 to $3.765 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. 25% of the shares subject to the Option vested on June 12, 2024. The remaining shares subject to the Option shall vest as follows: 25% of the shares in equal quarterly installments over the next two (2) quarterly vesting dates; 33 1/3% of the shares in equal quarterly installments over the next four (4) quarterly vesting dates; and 16 2/3% of the shares in equal quarterly installments over the next four (4) quarterly vesting dates, subject to the recipient's continuous service through each vesting date.
Key Figures
Options exercised: 50,000 shares
Shares sold: 70,000 shares
Exercise price: $2.48 per share
+4 more
7 metrics
Options exercised
50,000 shares
Employee stock options converted to Class A common stock on July 27, 2026
Shares sold
70,000 shares
Total Class A common shares sold in two transactions on July 27, 2026
Exercise price
$2.48 per share
Exercise price of the Employee Stock Option (Right to Buy)
Weighted average sale price (50,000 shares)
$3.7741 per share
50,000-share sale; individual trades from $3.65 to $3.825 per share
Weighted average sale price (20,000 shares)
$3.7389 per share
20,000-share sale; individual trades from $3.645 to $3.765 per share
Options remaining
372,543 shares
Employee stock options held directly after the reported exercise
Rule 10b5-1 plan date
March 17, 2026
Date the Rule 10b5-1 trading plan governing these transactions was entered
Key Terms
Rule 10b5-1 plan, weighted average sale price, Employee Stock Option (Right to Buy), quarterly vesting dates
4 terms
Rule 10b5-1 plan regulatory
"This transaction was made pursuant to a Rule 10b5-1 plan entered into on March 17, 2026"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted average sale price financial
"The reported price in Column 4 is a weighted average sale price"
Employee Stock Option (Right to Buy) financial
"Security title is Employee Stock Option (Right to Buy)"
quarterly vesting dates financial
"shares vest in equal quarterly installments over the next quarterly vesting dates"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Stitch Fix (SFIX) report for Anthony Bacos?
Stitch Fix reported that CTO Anthony Bacos exercised 50,000 employee stock options at $2.48 per share and sold 70,000 shares of Class A common stock on July 27, 2026, in a series of open-market transactions.
Were the recent SFIX insider trades by Anthony Bacos under a Rule 10b5-1 plan?
Yes, all reported transactions were made under a Rule 10b5-1 trading plan entered on March 17, 2026. This indicates the trades followed a pre-arranged schedule rather than discretionary timing based on subsequent market or company developments.
What was the option exercise detail for the Stitch Fix (SFIX) CTO?
Anthony Bacos exercised 50,000 Employee Stock Options with an exercise price of $2.48 per share, converting them into an equal number of Class A common shares. After this exercise, he held 372,543 options directly, according to the Form 4 filing.
What vesting schedule applies to the options exercised by the SFIX CTO?
The option had 25% of shares vest on June 12, 2024, with remaining shares vesting in staged quarterly installments over several future vesting dates, contingent on continuous service, as described in the option’s detailed vesting footnote.